Skip to main content

Find Clinical Trials

Home
Conditions
Platinum-resistant Recurrent Ovarian Cancer (PROC)

Clinical trial condition

Platinum-resistant Recurrent Ovarian Cancer (PROC)

Explore clinical trials studying Platinum-resistant Recurrent Ovarian Cancer (PROC). Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Platinum-resistant Recurrent Ovarian Cancer (PROC) trial results

Not Yet Recruiting

A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.

NCT07462468

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Study on the Efficacy and Safety of Sacituzumab Tirumotecan Combined With Bevacizumab in Platinum-Resistant Recurrent Ovarian Cancer

NCT07314619

Conditions: Platinum-resistant Recurrent Ovarian Cancer (PROC)
Locations: The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China

View Trial Details